The aim is to improve clinical decision-making by introducing a data-driven approach that must:
This is phase 1 of a potential 2-phase competition. A decision to proceed with phase 2 will depend on the outcomes from phase 1 and assessment of a separate application into a subsequent phase 2 competition. Only successful applicants from phase 1 will be able to apply to take part in phase 2.
Projects are expected to start by 5 May 2021 and can last up to 3 months.
To lead a project, you can:
Contracts will be awarded only to a single legal entity. However, if you can justify subcontracting components of the work, you can employ specialist consultants or advisers. This work will still be the responsibility of the main contractor.
Phase 1 - Feasibility study R&D contracts of up to £10,000, inclusive of VAT will be awarded for each successful project for up to 3 months.
Phase 2 - The second phase involves up to 2 contracts being awarded to organisations chosen from the successful phase 1 applicants. Up to £55,000 inclusive of VAT will be awarded for each contract, to develop a prototype and undertake field testing for up to 9 months.
Multi-morbidity (two or more concurrent chronic conditions) is associated with poor quality health, reduced life expectancy, greater levels of social exclusion, and reduced employment opportunities.
Currently the identification and characterisation of multi-morbidity is hindered by poor real-time access to fragmented individual data sets. This leads to delays in clinicians being able to make rapid, informed recommendations on the best next steps in a person’s care journey.
The aim is to develop a data-driven solution that can improve and personalize the care plans for patients with multimorbidity when they have an emergency admission to hospital by introducing analytical models in the clinical system that could assist with the risk assessment of patients.
In phase 1, you must:
At this stage contracts will be awarded for phase 1 only. You must define your goals and outline your plan for phase 2. This is part of the full commercial implementation in your phase 1 proposal.
You must demonstrate a credible and practical route to market, so your application must include a plan to commercialise your results.
Will not fund projects that cover: